new_0222_0376|IMGO|Short Name|0|0|total_current_assets|cash_on_hand|inventories_net|net_ppe|goodwill_and_intangible|liabilities|total_current_liabilities|total_long_term_liab|total_deposits|book_value_of_equity|retained_earnings|treasury_stock|ev_revenues|ev_earnings|ev_free_cash_flow|ev_assets|ps_ratio|pe_ratio|price_to_book_value|peg_ratio|debt_equity_ratio|dividend_yield|shareholder_yield_ttm|percent_of_shares_outstanding|receivables|payables|capital_stock|return_on_invested_capital|quality_ratio_fractile|momentum_fractile|market_beta_12_month|sustainable_growth_rate|institutional_investor_ownership_percentage|average_shares_outs_diluted|total_employee_number|eps|sga_expense|shares_outstanding|repurchase_of_capital_stock|ordinary_shares_number|payout_ratio|quick_ratio|normalized_eps|stock_buyback|effective_tax_rate|return_on_equity|net_income_ttm|revenues_ttm|dividend_per_share|revenues|gross_profit|pre_tax_income|net_income|interest_income|price|total_return_price|enterprise_value|average_volume_30|one_year_return|short_interest|forward_pe_ratio|forward_pe_ratio_1y|forward_ps_ratio|forward_ps_ratio_1y|quarterly_eps_estimates|quarterly_sales_estimates|quarterly_eps_surprise|quarterly_sales_surprise|quarterly_eps_actual|quarterly_sales_actual|sales_est_0y|sales_est_1y|price_target|consensus_recommendation|price_target_num_est|eps_est_0y|eps_est_1y|r_and_d_expense|reconciled_depreciation|interest_expense_non_operating|land_and_improvements|buildings_and_improvements|other_properties|machinery_furniture_equipment
new_0222_0376|IMGO|Long Name|1|1|Imago BioSciences Inc Total Current Assets (Quarterly) (USD)|Imago BioSciences Inc Cash and Short Term Investments (Quarterly) (USD)|Imago BioSciences Inc Inventories (Quarterly) (USD)|Imago BioSciences Inc Net PP&E (Quarterly) (USD)|Imago BioSciences Inc Goodwill and Intangibles (Quarterly) (USD)|Imago BioSciences Inc Total Liabilities (Quarterly) (USD)|Imago BioSciences Inc Total Current Liabilities (Quarterly) (USD)|Imago BioSciences Inc Total Long Term Liabilities (Quarterly) (USD)|Imago BioSciences Inc Total Deposits (Quarterly) (USD)|Imago BioSciences Inc Book Value (Quarterly) (USD)|Imago BioSciences Inc Retained Earnings (Quarterly) (USD)|Imago BioSciences Inc Treasury Stock (Quarterly) (USD)|Imago BioSciences Inc EV to Revenues|Imago BioSciences Inc EV to Earnings|Imago BioSciences Inc EV to Free Cash Flow|Imago BioSciences Inc EV to Assets (Quarterly)|Imago BioSciences Inc PS Ratio|Imago BioSciences Inc PE Ratio|Imago BioSciences Inc Price to Book Value|Imago BioSciences Inc PEG Ratio|Imago BioSciences Inc Debt to Equity Ratio|Imago BioSciences Inc Dividend Yield|Imago BioSciences Inc Shareholder Yield (TTM)|Imago BioSciences Inc Percent of Shares Outstanding Short|Imago BioSciences Inc Total Receivables (Quarterly) (USD)|Imago BioSciences Inc Total Payables (Quarterly) (USD)|Imago BioSciences Inc Total Capital Stock (Quarterly) (USD)|Imago BioSciences Inc Return on Invested Capital|Imago BioSciences Inc Quality Ratio Score|Imago BioSciences Inc Momentum Score|Imago BioSciences Inc Beta (1Y)|Imago BioSciences Inc Sustainable Growth Rate (TTM)|Imago BioSciences Inc Institutional Investor Ownership Percentage|Imago BioSciences Inc Average Diluted Shares Outstanding (Quarterly)|Imago BioSciences Inc Total Employees (Annual)|Imago BioSciences Inc EPS Diluted (Quarterly) (USD)|Imago BioSciences Inc SG&A Expense (Quarterly) (USD)|Imago BioSciences Inc Shares Outstanding|Imago BioSciences Inc Repurchase of Capital Stock (Quarterly) (USD)|Imago BioSciences Inc Ordinary Shares Number (Quarterly)|Imago BioSciences Inc Payout Ratio|Imago BioSciences Inc Quick Ratio (Quarterly)|Imago BioSciences Inc Normalized Diluted EPS (Quarterly) (USD)|Imago BioSciences Inc Stock Buybacks (Quarterly) (USD)|Imago BioSciences Inc Effective Tax Rate (TTM)|Imago BioSciences Inc Return on Equity|Imago BioSciences Inc Net Income (TTM) (USD)|Imago BioSciences Inc Revenue (TTM) (USD)|Imago BioSciences Inc Dividend Per Share (Quarterly) (USD)|Imago BioSciences Inc Revenue (Quarterly) (USD)|Imago BioSciences Inc Gross Profit (Quarterly) (USD)|Imago BioSciences Inc Pre-Tax Income (Quarterly) (USD)|Imago BioSciences Inc Net Income (Quarterly) (USD)|Imago BioSciences Inc Net Interest Income (Quarterly) (USD)|Imago BioSciences Inc Price (USD)|Imago BioSciences Inc Total Return Price (USD)|Imago BioSciences Inc Enterprise Value (USD)|Imago BioSciences Inc 30-Day Average Daily Volume|Imago BioSciences Inc 1 Year Price Returns (Daily)|Imago BioSciences Inc Short Interest|Imago BioSciences Inc PE Ratio (Forward)|Imago BioSciences Inc PE Ratio (Forward 1y)|Imago BioSciences Inc PS Ratio (Forward)|Imago BioSciences Inc PS Ratio (Forward 1y)|Imago BioSciences Inc Quarterly EPS Estimates (USD)|Imago BioSciences Inc Quarterly Revenue Estimates (USD)|Imago BioSciences Inc Quarterly EPS Surprise|Imago BioSciences Inc Quarterly Revenue Surprise|Imago BioSciences Inc Quarterly Actual EPS (USD)|Imago BioSciences Inc Quarterly Actual Revenue (USD)|Imago BioSciences Inc Revenue Estimates for Current Fiscal Year (USD)|Imago BioSciences Inc Revenue Estimates for Next Fiscal Year (USD)|Imago BioSciences Inc Price Target (USD)|Imago BioSciences Inc Consensus Recommendation|Imago BioSciences Inc Price Target Num Estimates|Imago BioSciences Inc EPS Estimates for Current Fiscal Year (USD)|Imago BioSciences Inc EPS Estimates for Next Fiscal Year (USD)|Imago BioSciences Inc Research and Development Expense (Quarterly) (USD)|Imago BioSciences Inc Reconciled Depreciation (Quarterly) (USD)|Imago BioSciences Inc Non-Operating Interest Expense (Quarterly) (USD)|Imago BioSciences Inc Land and Improvements (Quarterly) (USD)|Imago BioSciences Inc Buildings and Improvements (Quarterly) (USD)|Imago BioSciences Inc Other Properties (Quarterly) (USD)|Imago BioSciences Inc Machine, Furniture & Equipment (Quarterly) (USD)
new_0222_0376|IMGO|Unit|2|2|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|percent_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_beta|percent_USD_metric|percent_USD_metric|mil_figure_USD_metric|figure_whole_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_per_share_metric|percent_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_USD_metric|figure_whole_USD_price|figure_money_USD_per_share_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric
new_0222_0376|IMGO||4|4|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|quarterly|quarterly|daily|quarterly|quarterly|daily|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|quarterly|monthly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly
new_0222_0376|IMGO||5|5|91|91|0|91|0|91|91|91|0|91|91|0|0|0|1.43708609272|0|0|0|1.4387755102|0|0|1.43708609272|0|15.4166666667|0|91|91|0|0|0|0|0|30.6666666667|91.3333333333|92|91.3333333333|91.3333333333|19.3333333333|0|91|0|0|91.3333333333|0|0|0|91|0|0|0|0|91.3333333333|91.3333333333|91.3333333333|1.43708609272|1.43708609272|1.43708609272|1.44262295082|0|15.4166666667|0|0|0|0|91.5|91.5|92|0|92|92|47|62.6666666667|47|18.8|47|26.8571428571|25|91.3333333333|91.3333333333|0|0|0|0|0
new_0222_0376|IMGO||6|6|3|3|0|3|0|3|3|3|0|3|3|0|0|0|151|0|0|0|98|0|0|151|0|12|0|3|3|0|0|0|0|0|6|6|1|6|6|6|0|3|0|0|6|0|0|0|3|0|0|0|0|6|6|6|151|151|151|122|0|12|0|0|0|0|6|6|1|0|1|1|4|3|4|10|4|7|5|6|6|0|0|0|0|0
new_0222_0376|IMGO||7|7|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|daily|daily|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|yearly|quarterly|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|market_daily|market_daily|daily|market_daily|market_daily|daily|daily|daily|daily|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|daily|daily|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly
new_0222_0376|IMGO|202003|202003|202003||||||||||||||||||||||||||||||||||22.4657||-0.189|0.501||||||-0.189|||||||||-4.245|-4.245|0.006||||||||||||||||||||||||3.692|0|||||
new_0222_0376|IMGO|202006|202006|202006||||||||||||||||||||||||||||||||||22.4657||-0.166|0.649||||||-0.166|||||||||-3.73|-3.73|0||||||||||||||||||||||||3.354|0|||||
new_0222_0376|IMGO|202009|202009|202009||||||||||||||||||||||||||||||||||22.4657||-0.1918|0.734||||||-0.1918|||||||||-4.308|-4.308|0.008||||||||||||||||||||||||3.576||||||
new_0222_0376|IMGO|202012|202012|202012|77.822|76.641||0.008||167.717|5.105|162.612||-68.784|-70.342|||||||||||||||1.379|0|||||||22.4657||-0.247|1.292|||30.799|||-0.247||||-17.833|||||-5.547|-5.55|0.034||||||||||||||||||||||||4.274||||||
new_0222_0376|IMGO|202103|202103|202103|84.66|82.74||0.005||168.94|6.328|162.612||-75.562|-77.451|||||||||||||||2.768|0|||||||22.4657||-0.32|2.376|||30.799|||-0.32||||-20.697|||||-7.109|-7.109|0.087||||||||||||||||||||||||4.772|0.003|||||
new_0222_0376|IMGO|202106|202106|202106|82.635|81.109||0.004||169.007|6.395|162.612||-83.819|-86.257|||||||||||||||1.964|0|||||||30.799|17|-0.2859|1.743|||30.799|||-0.2859||||-25.773|||||-8.806|-8.806|0.082|||||||||||-0.38|0|-2039.4737||-8.13|0||||||||7.099|0.001|||||
new_0222_0376|IMGO|202107|202106|202106|||||||||||||||-22.2027|||||||0||0.5073|||||||||42.1592|||||33.3757|||||||||||||||||18.32|18.32|530.3338|||169318||||||||||||||||||||||||
new_0222_0376|IMGO|202108|202106|202106|||||||||||||||-33.3739|||||||0||0.4678|||||||||42.4551|||||33.4327|||||||||||||||||26.27|26.27|797.168|93241.6667||156405|||||||||||0|0|32|1|3|-5.935|-1.87|||||||
new_0222_0376|IMGO|202109|202109|202109|234.598|230.353||0.007||8.911|8.911|0||228.364|-97.927||||-14.0369||||2.9345|||0||1.869||1.905|0.003||||||86.767|26.6715|20|-0.44|3.04|33.457||33.457|||-0.44|-163.741|||-33.135|||||-11.67|-11.67|0.072|20.03|20.03|439.7907|211025.4667||625301|||||-0.33|0|-33.3333||-0.44|0||||1||||8.68|-0.001|||||
new_0222_0376|IMGO|202110|202109|202109|||||||||||||||-21.0741||||3.9|||0||3.0864|||||||||87.578||||||||||||||||||||||26.62|26.62|660.2723|112607.0333||1032634||||||||||||||||||||||||
new_0222_0376|IMGO|202111|202109|202109|||||||||||||||-16.5869||||3.2844|||0||3.5561|||||||||88.2174|||||33.5287|||||||||||||||||22.37|22.37|519.684|95780.8667||1192307|||||||||||||33|1|3|-6.115|-2.02|||||||
new_0222_0376|IMGO|202112|202112|202112|||||||||||||||-18.0209||||3.4811|||0||5.2896|||||||||88.5279||||||||||||||||||||||23.71|23.71|564.6125|231657.8||1773532|||||-0.3775|0|||||0||35.3333|1|3|-4.0925|-1.8067|||||||
new_0222_0376|IMGO|202201|202112|202112|||||||||||||||-14.2861||||2.9687|||0||5.6803|||||||||88.5018||||||||||||||||||||||20.22|20.22|447.5973|296605.8333||1904546||||||||||||||||||||||||
new_0222_0376|IMGO|202202|202112|202112|||||||||||||||-16.1481||||3.2242|||0|||||||||||||||||||||||||||||||||21.96|21.96|505.9373|299853.3|||||||||||||0|0|35.75|1.2|4|-1.77||||||||
new_0222_0376|IMGO|202203|202203|202203|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-0.3933|0||||||||||||||||||
new_0222_0376|IMGO|202206|202206|202206|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-0.45|0||||||||||||||||||
new_0222_0376|IMGO|202209|202209|202209|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-0.4933|0||||||||||||||||||
new_0222_0376|IMGO|202212|202212|202212|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-0.56|0||||||||||||||||||